Susquehanna International Group, LLP Eagle Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$3.34 - $5.6 $34,736 - $58,239	10,400 New	10,400 $58,000
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $856,834 - $1.06 Million	-18,700 Reduced 79.24%	4,900 $250,000
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $1.03 Million - $1.32 Million	23,600 New	23,600 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $713,412 - $877,914	-17,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $99,954 - $138,456	-2,700 Reduced 13.64%	17,100 $726,000
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $112,424 - $143,052	2,600 Added 15.12%	19,800 $950,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $2.32 Million - $4.05 Million	-67,500 Reduced 79.69%	17,200 $791,000
Q4 2019 Feb 14, 2020	BUY	$54.32 - $64.31 $3.94 Million - $4.67 Million	72,600 Added 600.0%	84,700 $5.09 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $1.96 Million - $2.21 Million	-36,800 Reduced 75.26%	12,100 $684,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $1.17 Million - $1.47 Million	25,100 Added 105.46%	48,900 $2.72 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $962,633 - $1.29 Million	-24,900 Reduced 51.13%	23,800 $1.2 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $3.87 Million - $7.15 Million	-105,500 Reduced 68.42%	48,700 $1.96 Million
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $2.68 Million - $3.37 Million	40,200 Added 35.26%	154,200 $10.7 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $2.36 Million - $3.53 Million	46,100 Added 67.89%	114,000 $8.63 Million
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $537,248 - $688,658	10,300 Added 17.88%	67,900 $3.58 Million
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $1.19 Million - $1.45 Million	23,900 Added 70.92%	57,600 $3.08 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $1.57 Million - $2.03 Million	33,700	33,700 $2.01 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account